The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006.
The global Ranolazine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ranolazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ranolazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ranolazine in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ranolazine include Gilead Sciences, Lupin, Teva and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ranolazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranolazine.
Report Scope
The Ranolazine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ranolazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranolazine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Lupin
Teva
Ajanta Pharma
Segment by Type
500 mg Tablet
1000 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranolazine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006.
The global Ranolazine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ranolazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ranolazine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ranolazine in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ranolazine include Gilead Sciences, Lupin, Teva and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ranolazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranolazine.
Report Scope
The Ranolazine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ranolazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranolazine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Lupin
Teva
Ajanta Pharma
Segment by Type
500 mg Tablet
1000 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranolazine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranolazine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 500 mg Tablet
1.2.3 1000 mg Tablet
1.3 Market by Application
1.3.1 Global Ranolazine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ranolazine Market Perspective (2019-2030)
2.2 Ranolazine Growth Trends by Region
2.2.1 Global Ranolazine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ranolazine Historic Market Size by Region (2019-2024)
2.2.3 Ranolazine Forecasted Market Size by Region (2025-2030)
2.3 Ranolazine Market Dynamics
2.3.1 Ranolazine Industry Trends
2.3.2 Ranolazine Market Drivers
2.3.3 Ranolazine Market Challenges
2.3.4 Ranolazine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ranolazine Players by Revenue
3.1.1 Global Top Ranolazine Players by Revenue (2019-2024)
3.1.2 Global Ranolazine Revenue Market Share by Players (2019-2024)
3.2 Global Ranolazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ranolazine Revenue
3.4 Global Ranolazine Market Concentration Ratio
3.4.1 Global Ranolazine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranolazine Revenue in 2023
3.5 Ranolazine Key Players Head office and Area Served
3.6 Key Players Ranolazine Product Solution and Service
3.7 Date of Enter into Ranolazine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ranolazine Breakdown Data by Type
4.1 Global Ranolazine Historic Market Size by Type (2019-2024)
4.2 Global Ranolazine Forecasted Market Size by Type (2025-2030)
5 Ranolazine Breakdown Data by Application
5.1 Global Ranolazine Historic Market Size by Application (2019-2024)
5.2 Global Ranolazine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ranolazine Market Size (2019-2030)
6.2 North America Ranolazine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ranolazine Market Size by Country (2019-2024)
6.4 North America Ranolazine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ranolazine Market Size (2019-2030)
7.2 Europe Ranolazine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ranolazine Market Size by Country (2019-2024)
7.4 Europe Ranolazine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ranolazine Market Size (2019-2030)
8.2 Asia-Pacific Ranolazine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ranolazine Market Size by Region (2019-2024)
8.4 Asia-Pacific Ranolazine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ranolazine Market Size (2019-2030)
9.2 Latin America Ranolazine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ranolazine Market Size by Country (2019-2024)
9.4 Latin America Ranolazine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ranolazine Market Size (2019-2030)
10.2 Middle East & Africa Ranolazine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ranolazine Market Size by Country (2019-2024)
10.4 Middle East & Africa Ranolazine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Ranolazine Introduction
11.1.4 Gilead Sciences Revenue in Ranolazine Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Lupin
11.2.1 Lupin Company Detail
11.2.2 Lupin Business Overview
11.2.3 Lupin Ranolazine Introduction
11.2.4 Lupin Revenue in Ranolazine Business (2019-2024)
11.2.5 Lupin Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Ranolazine Introduction
11.3.4 Teva Revenue in Ranolazine Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Detail
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Ranolazine Introduction
11.4.4 Ajanta Pharma Revenue in Ranolazine Business (2019-2024)
11.4.5 Ajanta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ranolazine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 500 mg Tablet
Table 3. Key Players of 1000 mg Tablet
Table 4. Global Ranolazine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Ranolazine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ranolazine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Ranolazine Market Share by Region (2019-2024)
Table 8. Global Ranolazine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Ranolazine Market Share by Region (2025-2030)
Table 10. Ranolazine Market Trends
Table 11. Ranolazine Market Drivers
Table 12. Ranolazine Market Challenges
Table 13. Ranolazine Market Restraints
Table 14. Global Ranolazine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Ranolazine Market Share by Players (2019-2024)
Table 16. Global Top Ranolazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranolazine as of 2023)
Table 17. Ranking of Global Top Ranolazine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Ranolazine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ranolazine Product Solution and Service
Table 21. Date of Enter into Ranolazine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ranolazine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Ranolazine Revenue Market Share by Type (2019-2024)
Table 25. Global Ranolazine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Ranolazine Revenue Market Share by Type (2025-2030)
Table 27. Global Ranolazine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Ranolazine Revenue Market Share by Application (2019-2024)
Table 29. Global Ranolazine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Ranolazine Revenue Market Share by Application (2025-2030)
Table 31. North America Ranolazine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Ranolazine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Ranolazine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Ranolazine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Ranolazine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Ranolazine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Ranolazine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Ranolazine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Ranolazine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ranolazine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Ranolazine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Ranolazine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Ranolazine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Ranolazine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Ranolazine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Gilead Sciences Company Detail
Table 47. Gilead Sciences Business Overview
Table 48. Gilead Sciences Ranolazine Product
Table 49. Gilead Sciences Revenue in Ranolazine Business (2019-2024) & (US$ Million)
Table 50. Gilead Sciences Recent Development
Table 51. Lupin Company Detail
Table 52. Lupin Business Overview
Table 53. Lupin Ranolazine Product
Table 54. Lupin Revenue in Ranolazine Business (2019-2024) & (US$ Million)
Table 55. Lupin Recent Development
Table 56. Teva Company Detail
Table 57. Teva Business Overview
Table 58. Teva Ranolazine Product
Table 59. Teva Revenue in Ranolazine Business (2019-2024) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Ajanta Pharma Company Detail
Table 62. Ajanta Pharma Business Overview
Table 63. Ajanta Pharma Ranolazine Product
Table 64. Ajanta Pharma Revenue in Ranolazine Business (2019-2024) & (US$ Million)
Table 65. Ajanta Pharma Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ranolazine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ranolazine Market Share by Type: 2023 VS 2030
Figure 3. 500 mg Tablet Features
Figure 4. 1000 mg Tablet Features
Figure 5. Global Ranolazine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Ranolazine Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Ranolazine Report Years Considered
Figure 10. Global Ranolazine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Ranolazine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Ranolazine Market Share by Region: 2023 VS 2030
Figure 13. Global Ranolazine Market Share by Players in 2023
Figure 14. Global Top Ranolazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranolazine as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Ranolazine Revenue in 2023
Figure 16. North America Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Ranolazine Market Share by Country (2019-2030)
Figure 18. United States Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Ranolazine Market Share by Country (2019-2030)
Figure 22. Germany Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Ranolazine Market Share by Region (2019-2030)
Figure 30. China Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Ranolazine Market Share by Country (2019-2030)
Figure 38. Mexico Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Ranolazine Market Share by Country (2019-2030)
Figure 42. Turkey Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Ranolazine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Gilead Sciences Revenue Growth Rate in Ranolazine Business (2019-2024)
Figure 45. Lupin Revenue Growth Rate in Ranolazine Business (2019-2024)
Figure 46. Teva Revenue Growth Rate in Ranolazine Business (2019-2024)
Figure 47. Ajanta Pharma Revenue Growth Rate in Ranolazine Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
